T. Ramtohul

Letter Re: “Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations”

Vincent Servois, Pier Paolo Mariani, T. Ramtohul

fr (code pays fourni par la source)

1656P Clinical and molecular outcomes of tebentafusp in metastatic uveal melanoma (MUM): A retrospective cohort of 168 patients

R. Sanchez, T. Ramtohul, Vincent Servois, Gaëlle Pierron et autres

fr (code pays fourni par la source)

LBA58 PLUME: A single-arm phase II trial of pembrolizumab (pembro) plus lenvatinib (lenva) in patients (pts) with metastatic uveal melanoma (mUM)

Manuel Jorge Rodrigues, Vincent Servois, R. Sanchez, Estelle Bastien et autres

fr (code pays fourni par la source)

Treatment toxicities and pathological response through the evolution of neoadjuvant regimens in early triple-negative breast cancer

Emmanuelle Arnaud, Pauline Vaflard, T. Ramtohul, Dalila MEZIANI et autres

Background Pembrolizumab-based neoadjuvant chemoimmunotherapy (CIT) is the new standard of care for high-risk early triple-negative breast cancer (eTNBC). The addition of multiple cytotoxic drugs can lead to cumulative toxicities. We report the evolution of chemotherapy (CT) practice and its impact on completion …

fr (code pays fourni par la source)

319TiP NeoBREASTIM: A phase II study of atezolizumab plus RP1 oncolytic immunotherapy in the neoadjuvant setting of triple-negative breast cancer (TNBC)

Estelle Bastien, Beatriz Grandal, R. Sanchez, T. Ramtohul et autres

fr (code pays fourni par la source)

263P Association between clinicopathological characteristics and pathological complete response in patients with triple negative breast cancer treated by neoadjuvant chemo-immunotherapy

Clara Helal, Lounes Djerroudi, T. Ramtohul, Enora Laas et autres

fr (code pays fourni par la source)

1130P Tebentafusp (tebe) in an ongoing cohort of 72 French patients (pts) with metastatic uveal melanoma (mUM)

Léah Mailly-Giacchetti, T. Ramtohul, Sylvaine Renault, Mathilde Saint‐Ghislain et autres

fr (code pays fourni par la source)

1485O Percutaneous uterine needle biopsy with microscopic and array-CGH analyses in patients with suspicious myometrial tumors on MRI: A prospective study

J. Smadja, V. Servois, G. Pierron, S. El Zein et autres

fr (code pays fourni par la source)